Simultaneous aortic and pulmonary valve replacement in repaired congenital heart disease.
Dmitry BobylevKlea HyskoMurat AvsarTomislav CvitkovicElena PetenaSamir SarikouchMechthild Westhoff-BleckGeorg HansmannAxel HaverichAlexander HorkePublished in: The Thoracic and cardiovascular surgeon (2023)
Single-stage aortic and pulmonary valve replacement after initial repair of CHD remains challenging with substantial perioperative mortality (8.3%). Nevertheless, long-term survival and clinical status at the latest follow-up were excellent. The valve type had no relevant impact on the postoperative course. The selection of the valves for implantation should take into account operation-specific factors - in particular re-operability - as well as the patients' wishes.
Keyphrases
- aortic valve
- congenital heart disease
- aortic stenosis
- transcatheter aortic valve replacement
- transcatheter aortic valve implantation
- aortic valve replacement
- ejection fraction
- end stage renal disease
- mitral valve
- pulmonary hypertension
- patients undergoing
- chronic kidney disease
- peritoneal dialysis
- left ventricular
- prognostic factors
- cardiac surgery
- cardiovascular disease
- type diabetes
- heart failure
- patient reported outcomes
- coronary artery
- aortic dissection